| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by GCS.
Page 3: 1 2 3 4 5 6 7 8 9
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 601 | 9 | 27 | 1530 1999 CLINICAL PHARMACOLOGY & THERAPEUTICS 65(5):483-490 Scheffler MR; Colburn W; Kook KA; Thomas SD Thalidomide does not alter estrogen-progesterone hormone single-dose pharmacokinetics | 12 | 12 |
| 602 | 4 | 13 | 1592 1999 ORGANIC PROCESS RESEARCH & DEVELOPMENT 3(2):139-140 Muller GW; Konnecke WE; Smith AM; Khetani VD A concise two-step synthesis of thalidomide | 5 | 12 |
| 603 | 4 | 8 | 1718 2000 GASTROENTEROLOGY 119(2):596-596 Fishman SJ; Feins NR; D'Amato RJ; Folkman J Thalidomide therapy for Crohn's disease | 5 | 12 |
| 604 | 7 | 16 | 1758 2000 MAYO CLINIC PROCEEDINGS 75(8):842-844 Federman GL; Federman DG Recalcitrant pyoderma gangrenosum treated with thalidomide | 5 | 12 |
| 605 | 2 | 8 | 1777 2000 ONCOLOGY-NEW YORK 14(12):29-32 Govindarajan R Irinotecan and thalidomide in metastatic colorectal cancer | 7 | 12 |
| 606 | 115 | 191 | 1823 2001 BIODRUGS 15(10):681-703 Meierhofer C; Dunzendorfer S; Wiedermann CJ Theoretical basis for the activity of thalidomide | 6 | 12 |
| 607 | 8 | 13 | 1918 2001 DRUG METABOLISM AND DISPOSITION 29(10):1355-1357 Teo SK; Harden JL; Burke AB; Noormohamed FH; Youle M; Johnson MA; Peters BS; Stirling DI; Thomas SD Thalidomide is distributed into human semen after oral dosing | 7 | 12 |
| 608 | 16 | 17 | 2011 2001 SEMINARS IN ONCOLOGY 28(6):602-606 Stirling D Thalidomide: A novel template for anticancer drugs | 7 | 12 |
| 609 | 13 | 38 | 2192 2002 GASTROENTEROLOGY 123(1):291-300 Enomoto N; Takei Y; Hirose M; Ikejima K; Miwa H; Kitamura T; Sato N Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production | 3 | 12 |
| 610 | 22 | 24 | 2223 2002 JOURNAL OF CLINICAL ONCOLOGY 20(11):2607-2609 Eisen T Thalidomide in solid malignancies | 6 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 611 | 20 | 24 | 2235 2002 JOURNAL OF INVESTIGATIVE DERMATOLOGY 119(5):1020-1026 Bastuji-Garin S; Ochonisky S; Bouche P; Gherardi RK; Duguet C; Djerradine Z; Poli F; Revuz J; Thalidomide Neuropathy Study Grp Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients | 9 | 12 |
| 612 | 11 | 38 | 2254 2002 LEUKEMIA 16(9):1609-1614 Piccaluga PP; Visani G; Pileri SA; Ascani S; Grafone T; Isidori A; Malagola M; Finelli C; Martinelli G; Ricci P; Baccarani M; Tura S Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study | 7 | 12 |
| 613 | 0 | 0 | 114 1962 LANCET 1(7222):222-& JONES EE; WILLIAMSON DAJ THALIDOMIDE AND CONGENITAL ABNORMALITIES | 0 | 11 |
| 614 | 0 | 7 | 243 1963 LANCET 2(731):889-& KAJII T; AKICHIKA M; DOHMEN S; SHINOHARA M; KIKUCHI K THALIDOMIDE AND UMBILICAL ARTERY | 1 | 11 |
| 615 | 1 | 2 | 248 1963 NATURE 199(489):1204-& DEBOCK CA; PETERS A EFFECT OF THALIDOMIDE ON DEVELOPMENT OF CHICK EMBRYO | 7 | 11 |
| 616 | 4 | 14 | 288 1964 LANCET 1(733):724-& FELISATI D TERATOGENIC ACTION OF THALIDOMIDE | 6 | 11 |
| 617 | 12 | 26 | 337 1965 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 13:181-& DWORNIK JJ; MOORE KL SKELETAL MALFORMATIONS IN HOLTZMAN RAT EMBRYO FOLLOWING ADMINISTRATION OF THALIDOMIDE | 5 | 11 |
| 618 | 5 | 9 | 372 1966 CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL 8(6):299-& CAZORT RJ; SONG YK A TRIAL OF THALIDOMIDE IN PROGRESSIVE LEPRA REACTIONS | 9 | 11 |
| 619 | 0 | 6 | 382 1966 JOURNAL OF DENTAL RESEARCH 45(6P2):1767-& CHAUDHRY AP; SCHWARTZ S; SCHMUTZ JA EFFECTS OF CORTISONE AND THALIDOMIDE ON MORPHOGENESIS OF SECONDARY PALATE IN A/HEJ MICE | 0 | 11 |
| 620 | 6 | 14 | 387 1966 JOURNAL OF REPRODUCTION AND FERTILITY 11(1):157-& FRITZ H FAILURE OF THALIDOMIDE METABOLITES TO PRODUCE MALFORMATIONS IN RABBIT EMBRYO | 8 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 621 | 2 | 4 | 390 1966 LANCET 1(7430):207-& FLOERSHE.GL ANOTHER CHANCE FOR THALIDOMIDE | 0 | 11 |
| 622 | 11 | 17 | 536 1971 TOXICOLOGY AND APPLIED PHARMACOLOGY 18(1):208-& LEHMANN H; NIGGESCH.A TERATOLOGIC EFFECTS OF THALIDOMIDE IN HIMALAYAN RABBITS | 2 | 11 |
| 623 | 1 | 3 | 598 1974 LANCET 1(7866):1111-1111 MCCREDIE J; MCLEOD JG THALIDOMIDE AND EMBRYONIC NEUROPATHY | 5 | 11 |
| 624 | 11 | 28 | 620 1976 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 18(2):189-197 STEPHENSON JBP EPILEPSY - NEUROLOGICAL COMPLICATION OF THALIDOMIDE EMBRYOPATHY | 7 | 11 |
| 625 | 0 | 0 | 628 1976 PHARMACOLOGIST 18(2):218-218 HASTINGS RC; MORALES MJ; SHANNON EJ STUDIES ON MECHANISM OF ACTION OF THALIDOMIDE IN LEPROSY | 8 | 11 |
| 626 | 5 | 17 | 647 1977 EXPERIENTIA 33(10):1384-1386 PETTER C EARLY FETAL THROMBOSIS INDUCED BY THALIDOMIDE IN MOUSE - POSSIBLE EXPLANATION FOR TERATOGENICITY | 7 | 11 |
| 627 | 1 | 5 | 747 1981 DERMATOLOGICA 162(2):86-90 SHESKIN J; GORODETZKY R; LOEWINGER E; WEINREB A INVIVO MEASUREMENTS OF IRON, COPPER AND ZINC IN THE SKIN OF PRURIGO NODULARIS PATIENTS TREATED WITH THALIDOMIDE | 3 | 11 |
| 628 | 0 | 0 | 840 1984 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 111(3):285-286 SCHNITZLER L THALIDOMIDE IN HAILEY-HAILEY DISEASE - GOOD BUT PALLIATIVE RESULTS | 4 | 11 |
| 629 | 0 | 1 | 1016 1990 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 263(11):1474-1474 RANDALL T INVESTIGATIONAL NEW DRUG (US) ORPHAN TRIALS NOW USE THALIDOMIDE FROM 2 SOURCES | 7 | 11 |
| 630 | 1 | 4 | 1022 1990 LANCET 335(8705):1591-1591 YOULE M; HAWKINS D; GAZZARD B THALIDOMIDE IN HYPERALGIC PHARYNGEAL ULCERATION OF AIDS | 9 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 631 | 32 | 85 | 1115 1994 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS 13(4):177-192 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 8 | 11 |
| 632 | 10 | 25 | 1146 1994 JOURNAL OF HEPATOLOGY 21(4):496-499 MCCORMICK PA; SCOTT F; EPSTEIN O; BURROUGHS AK; SCHEUER PJ; MCINTYRE N THALIDOMIDE AS THERAPY FOR PRIMARY BILIARY-CIRRHOSIS - A DOUBLE-BLIND PLACEBO-CONTROLLED PILOT-STUDY | 6 | 11 |
| 633 | 5 | 10 | 1187 1995 DIGESTIVE DISEASES AND SCIENCES 40(5):1147-1148 NAUM SM; MOLLOY PJ; KANIA RJ; MCGARR J; VANTHIEL DH USE OF THALIDOMIDE IN TREATMENT AND MAINTENANCE OF IDIOPATHIC ESOPHAGEAL ULCERS IN HIV+ INDIVIDUALS | 7 | 11 |
| 634 | 4 | 11 | 1216 1995 NATURE 375(6531):453-453 ASHBY J; TINWELL H IS THALIDOMIDE MUTAGENIC | 7 | 11 |
| 635 | 14 | 27 | 1314 1997 BIOCHEMICAL PHARMACOLOGY 53(10):1553-1557 Nicolai S; Sies H; Stahl W Stimulation of gap junctional intercellular communication by thalidomide and thalidomide analogs in human skin fibroblasts | 6 | 11 |
| 636 | 2 | 8 | 1333 1997 DERMATOLOGY 195(4):359-361 Ferrandiz C; Carrascosa JM; Just M; Bielsa I; Ribera M Sequential combined therapy with thalidomide and narrow-band (TLO1) UVB in the treatment of prurigo nodularis | 9 | 11 |
| 637 | 0 | 0 | 1443 1998 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 280(10):872-872 Nightingale SL Thalidomide approved for erythema nodosum leprosum | 9 | 11 |
| 638 | 0 | 0 | 1502 1999 BLOOD 94(10):125A-125A Shima Y; Treon SP; Yoshizaki K; Tai YT; Hideshima T; Raje N; Chauhan D; Davies F; Schlossman R; Anderson KC Clinical and biological activity of thalidomide (Thal) in multiple myeloma (MM). | 0 | 11 |
| 639 | 23 | 38 | 1622 2000 ANTI-CANCER DRUGS 11(10):787-791 Adlard JW Thalidomide in the treatment of cancer | 5 | 11 |
| 640 | 4 | 4 | 1624 2000 ARCHIVES OF DERMATOLOGY 136(12):1442-1443 Camisa C; Popovsky JL Effective treatment of oral erosive lichen planus with thalidomide | 6 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 641 | 0 | 0 | 1638 2000 BLOOD 96(11):167A-167A Yakoub-Agha I; Attal M; Dumontet C; Moreau P; Berthou C; Lamy T; Grosbois B; Dauriac C; Dorvaux I; Bay JO; Monconduit M; Harousseau JL; Duguet C; Facon T Thalidomide in patients with advanced myeloma: Survival prognostic factors. | 0 | 11 |
| 642 | 8 | 15 | 1748 2000 JOURNAL OF INFECTIOUS DISEASES 182(3):983-987 Lokensgard JR; Hu SX; van Fenema EM; Sheng WS; Peterson PK Effect of thalidomide on chemokine production by human microglia | 8 | 11 |
| 643 | 2 | 9 | 1940 2001 HAEMATOLOGICA 86(7):772-773 Pozzato G; Zorat F; Nascimben F; Comar C; Kikic F; Festini G Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia | 7 | 11 |
| 644 | 8 | 10 | 1941 2001 HAEMATOLOGICA 86(10):1108-1109 Camba L; Peccatori J; Pescarollo A; Tresoldi M; Corradini P; Bregni M Thalidomide and thrombosis in patients with multiple myeloma | 10 | 11 |
| 645 | 8 | 30 | 2051 2002 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 12(7):1043-1046 Noguchi T; Shimazawa R; Nagasawa K; Hashimoto Y Thalidomide and its analogues as cyclooxygenase inhibitors | 9 | 11 |
| 646 | 4 | 4 | 2221 2002 JOURNAL OF CLINICAL ONCOLOGY 20(5):1429-1430 Nathan PD; Gore ME; Eisen TG Unexpected toxicity of combination thalidomide and interferon alfa-2a treatment in metastatic renal cell carcinoma | 7 | 11 |
| 647 | 1 | 1 | 113 1962 LANCET 1(7220):100-& BURLEY DM THALIDOMIDE AND CONGENITAL ABNORMALITIES | 8 | 10 |
| 648 | 0 | 0 | 132 1962 LANCET 2(7247):151-& KAJII T THALIDOMIDE AND CONGENITAL DEFORMITIES | 5 | 10 |
| 649 | 4 | 10 | 166 1962 NEW ENGLAND JOURNAL OF MEDICINE 266(24):1268-& COHEN S THALIDOMIDE POLYNEUROPATHY | 8 | 10 |
| 650 | 0 | 7 | 247 1963 NATURE 198(488):1068-& BONEY AD ABNORMAL GROWTH OF SPORELINGS OF A MARINE RED ALGA INDUCED BY THALIDOMIDE | 3 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 651 | 2 | 21 | 313 1965 ARZNEIMITTEL-FORSCHUNG 15(5):508-& CHAMPYHA.S ACTION DE LIMIDAZOLE SUR LES PREMIERS METABOLITES DE LA THALIDOMIDE - ETUDE DE LA SCISSION DU NOYAU PHTALIMIDE | 0 | 10 |
| 652 | 7 | 17 | 315 1965 BIOCHEMICAL PHARMACOLOGY 14(5):893-& GERSHBEI.LL EFFECT OF THALIDOMIDE ON RAT LIVER REGENERATION AND DIAPHRAGM CARBOHYDRATE METABOLISM | 0 | 10 |
| 653 | 10 | 22 | 323 1965 CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 43(1):69-& MCCOLL JD; GLOBUS M; ROBINSON S AN ATTEMPTED REVERSAL OF THALIDOMIDE EMBRYOPATHY IN RAT BY GLUTAMINE | 7 | 10 |
| 654 | 6 | 18 | 451 1968 ARZNEIMITTEL-FORSCHUNG 18(10):1313-& BRODE E EXPERIMENTAL STUDIES ON CYCLIC IMIDES .4. CLEAVING OF PHTHALIMIDE RING IN THALIDOMIDE BY AMINES | 6 | 10 |
| 655 | 14 | 36 | 534 1971 TERATOLOGY 4(4):409-& NUDLEMAN KL; TRAVILL AA MORPHOLOGICAL AND HISTOCHEMICAL STUDY OF THALIDOMIDE-INDUCED UPPER LIMB MALFORMATIONS IN RABBIT FETUSES | 3 | 10 |
| 656 | 3 | 15 | 571 1973 JOURNAL OF MEDICAL PRIMATOLOGY 2(5):267-276 HENDRICK.AG SENSITIVE PERIOD AND MALFORMATION SYNDROME PRODUCED BY THALIDOMIDE IN CRAB-EATING MONKEY (MACACA-FASCICULARIS) | 0 | 10 |
| 657 | 2 | 2 | 573 1973 LANCET 2(7824):324-325 LEVY L; FASAL P; LEVAN NE; FREEDMAN RI TREATMENT OF ERYTHEMA-NODOSUM LEPROSUM WITH THALIDOMIDE | 8 | 10 |
| 658 | 0 | 15 | 624 1976 JOURNAL OF THE INDIAN CHEMICAL SOCIETY 53(10):1049-1052 DE AU; PAL D QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP (QSAR) AND RATIONAL DRUG DESIGN FOR SOME ANTINEOPLASTIC THALIDOMIDE AND GLUTARIMIDE DERIVATIVES | 0 | 10 |
| 659 | 5 | 36 | 744 1981 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 31-1(2):315-320 FLOHE L; DRAEGER E; FRANKUS E; GRAUDUMS I; GUNZLER WA; HELM FC; KUUTTISAVOLAINEN ER STUDIES ON THE HYPOTHETICAL RELATIONSHIP OF THALIDOMIDE-INDUCED EMBRYOPATHY AND COLLAGEN BIOSYNTHESIS | 0 | 10 |
| 660 | 15 | 36 | 914 1986 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 36-2(7):1138-1141 GUNZLER V; HANAUSKEABEL HM; TSCHANK G; SCHULTEWISSERMANN H IMMUNOLOGICAL EFFECTS OF THALIDOMIDE - INACTIVITY OF THE DRUG AND SEVERAL OF ITS HYDROLYSIS PRODUCTS IN MONONUCLEOCYTE PROLIFERATION TESTS | 0 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 661 | 5 | 17 | 937 1986 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 41(11-12):1057-1061 KOCH HP; CZEJKA MJ EVIDENCE FOR THE INTERCALATION OF THALIDOMIDE INTO DNA - CLUE TO THE MOLECULAR MECHANISM OF THALIDOMIDE TERATOGENICITY | 8 | 10 |
| 662 | 12 | 32 | 941 1987 ARCHIVES OF TOXICOLOGY 60(5):376-381 STERZ H; NOTHDURFT H; LEXA P; OCKENFELS H TERATOLOGIC STUDIES ON THE HIMALAYAN RABBIT - NEW ASPECTS OF THALIDOMIDE-INDUCED TERATOGENESIS | 6 | 10 |
| 663 | 3 | 4 | 1057 1992 GENITOURINARY MEDICINE 68(6):424-425 STRAZZI S; LEBBE C; GEOFFRAY C; ABLON G; MOREL P; VEROLA O; MOLINA JM APHTHOUS ULCERS IN HIV-INFECTED PATIENTS - TREATMENT WITH THALIDOMIDE | 8 | 10 |
| 664 | 0 | 0 | 1108 1993 PEDIATRIC DERMATOLOGY 10(3):283-285 MENNI S; IMONDI D; BRANCALEONE W; CROCI S RECURRENT GIANT APHTHOUS ULCERS IN A CHILD - PROTRACTED TREATMENT WITH THALIDOMIDE | 5 | 10 |
| 665 | 13 | 24 | 1141 1994 FOLIA BIOLOGICA 40(4):161-171 BILA V; KREN V EVIDENCE FOR TERATOGENICITY OF THALIDOMIDE USING CONGENIC AND RECOMBINANT INBRED RAT STRAINS | 0 | 10 |
| 666 | 3 | 30 | 1154 1994 MIKROCHIMICA ACTA 117(1-2):75-85 AUCELIO RQ; CAMPIGLIA AD PHARMACEUTICAL FORMULATION ANALYSIS OF THALIDOMIDE BY SOLID-SURFACE ROOM-TEMPERATURE PHOSPHORIMETRY | 1 | 10 |
| 667 | 4 | 22 | 1170 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39(12):2807-2809 PETERSON PK; GEKKER G; BORNEMANN M; CHATTERJEE D; CHAO CC THALIDOMIDE INHIBITS LIPOARABINOMANNAN-INDUCED UP-REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION | 3 | 10 |
| 668 | 0 | 0 | 1209 1995 LANCET 346(8985):1289-1289 THOMPSON C THALIDOMIDE EFFECTIVE FOR AIDS-RELATED ORAL ULCERS | 5 | 10 |
| 669 | 8 | 9 | 1257 1996 DERMATOLOGY 193(4):321-323 Bonnetblanc JM; Royer C; Bedane C Thalidomide and recurrent aphthous stomatitis: A follow-up study | 5 | 10 |
| 670 | 10 | 12 | 1310 1997 ANALYTICA CHIMICA ACTA 339(1-2):91-97 Simmons BR; Lush RM; Figg WD A reversed-phase high performance liquid chromatography method using solid phase extraction to quantitate thalidomide in human serum | 8 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 671 | 8 | 26 | 1399 1998 ARCHIV DER PHARMAZIE 331(1):7-12 Teubert U; Zwingenberger K; Wnendt S; Eger K 5 '-substituted thalidomide analogs as modulators of TNF-alpha | 10 | 10 |
| 672 | 7 | 20 | 1408 1998 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 8(9):1071-1076 Niwayama S; Loh C; Turk BE; Liu JO; Miyachi H; Hashimoto Y Enhanced potency of perfluorinated thalidomide derivatives for inhibition of LPS-induced tumor necrosis factor-alpha production is associated with a change of mechanism of action | 8 | 10 |
| 673 | 18 | 33 | 1477 1998 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 48(4):397-402 Zhu J; Deng GM; Diab A; Zwingenberger K; Bakhiet M; Link H Thalidomide prolongs experimental autoimmune neuritis in Lewis rats | 4 | 10 |
| 674 | 15 | 23 | 1535 1999 DRUG SAFETY 21(3):161-169 Lary JM; Daniel KL; Erickson JD; Roberts HE; Moore CA The return of thalidomide - Can birth defects be prevented? | 5 | 10 |
| 675 | 6 | 15 | 1565 1999 JOURNAL OF INFECTIOUS DISEASES 180(1):216-219 Meierhofer C; Dunzendorfer S; Wiederman CJ Protein kinase C-dependent effects on leukocyte migration of thalidomide | 5 | 10 |
| 676 | 7 | 32 | 1568 1999 JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS 15(5):429-438 Siefert B; Pleyer U; Muller M; Hartmann C; Keipert S Influence of cyclodextrins on the in vitro corneal permeability and in vivo ocular distribution of thalidomide | 0 | 10 |
| 677 | 11 | 13 | 1594 1999 PEDIATRICS 103(4):art. no.-e44 Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR Thalidomide in children undergoing bone marrow transplantation: Series at a single institution and review of the literature | 0 | 10 |
| 678 | 11 | 22 | 1597 1999 PHARMACOTHERAPY 19(10):1177-1180 Horowitz SB; Stirling AL Thalidomide-induced toxic epidermal necrolysis | 10 | 10 |
| 679 | 14 | 40 | 1598 1999 REPRODUCTIVE TOXICOLOGY 13(6):547-554 Hansen JM; Carney EW; Harris C Differential alteration by thalidomide of the glutathione content of rat vs. rabbit conceptuses in vitro | 6 | 10 |
| 680 | 5 | 11 | 1602 1999 SLEEP 22(1):113-115 Kanbayashi T; Shimizu T; Takahashi Y; Kitajima T; Takahashi K; Saito Y; Hishikawa Y Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study | 8 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 681 | 0 | 0 | 1636 2000 BLOOD 96(11):167A-167A Coleman M; Leonard JP; Nahum K; Michaeli J Non-myelosuppressive therapy with BLT-D (Biaxin (R), low dose thalidomide and dexamethasone) is highly active in Waldenstrom's macroglobulinemia and myeloma. | 0 | 10 |
| 682 | 0 | 0 | 1640 2000 BLOOD 96(11):168A-168A Weber DM; Rankin K; Gavino M; Delasalle K; Aguayo A; Albitar M; Alexanian R Angiogenesis factors and sensitivity to thalidomide in previously untreated multiple myeloma (MM). | 0 | 10 |
| 683 | 0 | 0 | 1648 2000 BLOOD 96(11):286B-286B Dimopoulos MA; Viniou N; Zomas A; Grigoraki V; Galani E; Matsouka C; Economou O; Anagnostopoulos N; Panayiotides P Treatment of Waldenstrom's macroglobulinemia with thalidomide. | 0 | 10 |
| 684 | 4 | 17 | 1736 2000 JOURNAL OF CHILD NEUROLOGY 15(8):497-503 Schoeman JF; Springer P; Ravenscroft A; Donald PR; Bekker LG; van Rensburg AJ; Hanekom WA; Haslett PAJ; Kaplan G Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role | 8 | 10 |
| 685 | 4 | 7 | 1801 2001 AMERICAN JOURNAL OF GASTROENTEROLOGY 96(4):1305-1306 Ginsburg PM; Hanan I; Ehrenpreis ED Treatment of severe esophageal Crohn's disease with thalidomide | 8 | 10 |
| 686 | 0 | 0 | 1874 2001 BLOOD 98(11):775A-775A Richardson PG; Schlossman RL; Hideshima T; Davies F; LeBlanc R; Catley L; Doss D; Kelly KA; McKenney M; Mechlowicz J; Freeman A; Deocampo R; Rich R; Ryoo J; Chauhan D; Munshi N; Weller E; Thomas S; Zeldis J; Anderson KC A phase 1 study of oral CC5013, an immunomodulatory thalidomide (Thal) derivative, in patients with relapsed and refractory multiple myeloma (MM). | 0 | 10 |
| 687 | 10 | 51 | 1899 2001 CANCER LETTERS 163(2):191-200 Myoung H; Hong SD; Kim YY; Hong SP; Kim MJ Evaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinoma | 4 | 10 |
| 688 | 39 | 60 | 1900 2001 CELLULAR AND MOLECULAR BIOLOGY 47(7):1105-1114 Settles B; Stevenson A; Wilson K; Mack C; Ezell T; Davis MF; Taylor LD Down-regulation of cell adhesion molecules LFA-1 and ICAM-1 after in vitro treatment with the anti-TNF-alpha agent thalidomide | 7 | 10 |
| 689 | 8 | 25 | 1908 2001 CLINICAL CANCER RESEARCH 7(11):3311-3313 Onn A; Tseng JE; Herbst RS Thalidomide, cyclooxygenase-2, and angiogenesis: Potential for therapy | 1 | 10 |
| 690 | 22 | 47 | 2010 2001 SEMINARS IN ONCOLOGY 28(6):597-601 D'Amato RJ; Lentzsch S; Anderson KC; Rogers MS Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma | 0 | 10 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 691 | 19 | 48 | 2046 2002 BIOMEDICINE & PHARMACOTHERAPY 56(1):31-35 Shek LPC; Lim DLC Thalidomide in Behcet's disease | 7 | 10 |
| 692 | 13 | 33 | 2147 2002 CANCER 95(4):758-765 Daliani DD; Papandreou CN; Thall PF; Wang XM; Perez C; Oliva R; Pagliaro L; Amato R A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma | 5 | 10 |
| 693 | 33 | 53 | 2170 2002 CURRENT OPINION IN ONCOLOGY 14(6):635-640 Raje N; Anderson KC Thalidomide and immunomodulatory drugs as cancer therapy | 5 | 10 |
| 694 | 41 | 67 | 2215 2002 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 6(2):160-174 Kumar S; Witzig TE; Rajkumar SV Thalidomide as an anti-cancer agent | 6 | 10 |
| 695 | 27 | 34 | 2290 2002 THERAPEUTIC DRUG MONITORING 24(1):104-110 Price DK; Ando Y; Kruger EA; Weiss M; Figg WD 5 '-OH-thalidomide, a metabolite of thalidomide, inhibits angiogenesis | 9 | 10 |
| 696 | 18 | 42 | 2340 2003 BLOOD 102(1):69-77 Mileshkin L; Biagi JJ; Mitchell P; Underhill C; Grigg A; Bell R; McKendrick J; Briggs P; Seymour JF; Lillie K; Smith JG; Zeldis JB; Prince HM Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age | 7 | 10 |
| 697 | 1 | 2 | 5 1960 AMERICAN JOURNAL OF PSYCHIATRY 116(11):1030-1031 COHEN S SLEEP REGULATION WITH THALIDOMIDE | 4 | 9 |
| 698 | 0 | 1 | 38 1961 BRITISH MEDICAL JOURNAL 2(526):1570-& BARTHOLOMAY A NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 0 | 9 |
| 699 | 0 | 0 | 122 1962 LANCET 1(7229):591-& SMITHELLS RW THALIDOMIDE AND CONGENITAL ABNORMALITIES | 7 | 9 |
| 700 | 1 | 1 | 148 1962 LANCET 2(7260):836-& HUGHES DT; PLAYFAIR JH; HOPPER PK; DELHANTY JD; CHITHAM RG CHROMOSOMES OF THALIDOMIDE-DEFORMED FOETUSES | 6 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 701 | 23 | 44 | 183 1963 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA 59(4):491-& BACH A; BICHEL J; HEJGAARD JJ STUDIES ON POSSIBLE ANTI-NEOPLASTIC EFFECT OF THALIDOMIDE | 4 | 9 |
| 702 | 4 | 10 | 239 1963 LANCET 1(729):1374-& NARROD SA; KING CTG METABOLIC STUDIES WITH THALIDOMIDE | 4 | 9 |
| 703 | 4 | 12 | 244 1963 LANCET 2(731):1068-& MILLER ZB INHIBITION OF TISSUE-CULTURE GROWTH BY A SOLUBLE THALIDOMIDE DERIVATIVE | 5 | 9 |
| 704 | 1 | 1 | 292 1964 NATURE 201(492):940-& GIACOMELLO G; QUAGLIA G; MALATEST.P ACTION OF THALIDOMIDE ON RADICAL MERISTEMS OF ALLIUM CEPA | 4 | 9 |
| 705 | 0 | 3 | 302 1964 SCIENCE 144(362):1583-& DIPAOLO JA; WENNER CE THALIDOMIDE - EFFECTS ON EHRLICH ASCITES TUMOR CELLS IN VITRO | 4 | 9 |
| 706 | 10 | 44 | 308 1965 ACTA RADIOLOGICA-DIAGNOSIS 3(3):225-& ROSENDAL T APLASIA-HYPOPLASIA OF OTIC LABYRINTH AFTER THALIDOMIDE | 0 | 9 |
| 707 | 0 | 6 | 333 1965 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 261(1):271-& CHAMPYHA.S LE GLUTARIMIDE ET LACTIVITE DE LA THALIDOMIDE . ETUDE SPECTRALE ETENDUE JUSQUE VERS 2050 A | 0 | 9 |
| 708 | 7 | 17 | 336 1965 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 13:159-& SALZGEBE.B; SALAUN J ACTION DE LA THALIDOMIDE SUR LEMBRYON DE POULET | 0 | 9 |
| 709 | 1 | 11 | 360 1966 ACTA PHARMACOLOGICA ET TOXICOLOGICA 24(4):443-& LARSEN V; BREDAHL E EMBRYOTOXIC EFFECT ON RABBITS OF MONOPHENYLBUTAZONE (MONAZAN) COMPARED WITH PHENYLBUTAZONE AND THALIDOMIDE | 1 | 9 |
| 710 | 5 | 8 | 473 1968 TRANSPLANTATION 6(3):476-& MOUZAS GL; GERSHON RK EFFECT OF THALIDOMIDE ON SKIN ALLOGRAFTS IN MICE - SURVIVAL OF GRAFTS | 8 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 711 | 4 | 12 | 484 1969 FOLIA PRIMATOLOGICA 10(3):195-& BARROW MV; STEFFEK AJ; KING CTG THALIDOMIDE SYNDROME IN RHESUS MONKEYS (MACACA MULATTA) | 4 | 9 |
| 712 | 0 | 0 | 593 1974 INTERNATIONAL JOURNAL OF DERMATOLOGY 13(1):20-25 KLUKEN N; WENTE W INDICATIONS FOR THALIDOMIDE THERAPY FOR LEPROSY | 7 | 9 |
| 713 | 2 | 8 | 630 1976 PHARMAZIE 31(7):492-493 OCKENFELS H; KOHLER F; MEISE W TERATOGENIC EFFECT AND STEREOSPECIFICITY OF A THALIDOMIDE METABOLITE | 4 | 9 |
| 714 | 5 | 16 | 642 1977 BRITISH JOURNAL OF SURGERY 64(3):203-204 SHAND JEG; BREMNER DN AGENESIS OF VERMIFORM APPENDIX IN A THALIDOMIDE CHILD | 4 | 9 |
| 715 | 4 | 19 | 650 1977 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 203(1):240-251 FREDERICKSON RCA; SLATER IH; DUSENBERRY WE; HEWES CR; JONES GT; MOORE RA COMPARISON OF THALIDOMIDE AND PENTOBARBITAL - NEW METHODS FOR IDENTIFYING NOVEL HYPNOTIC DRUGS | 0 | 9 |
| 716 | 0 | 7 | 738 1980 TERATOLOGY 22(2):183-185 SCOTT WJ; WILSON JG; HELM FC A METABOLITE OF A STRUCTURAL ANALOG OF THALIDOMIDE LACKS TERATOGENIC EFFECT IN PREGNANT RHESUS-MONKEYS | 7 | 9 |
| 717 | 4 | 18 | 759 1981 PATHOLOGIE BIOLOGIE 29(10):601-604 FAURE M; LEJEUNE JP; GAUCHERAND M; THIVOLET J PMN LEUKOCYTES CHEMOTAXIS - INHIBITION BY THALIDOMIDE | 6 | 9 |
| 718 | 20 | 39 | 780 1982 DERMATOLOGICA 165(4):355-362 SCOLARI F; HARMS M; GILARDI S THALIDOMIDE IN THE TREATMENT OF CHRONIC LUPUS-ERYTHEMATOSUS | 7 | 9 |
| 719 | 3 | 6 | 820 1983 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 7(8-9):751-751 COUZIGOU P; DOUTRE MS; HOUDEE G; RICHARDMOLARD B; FLUERY B; AMOURETTI M; BEYLOT C; BERAUD C THALIDOMIDE IN THE TREATMENT OF BEHCETS SYNDROME | 0 | 9 |
| 720 | 9 | 13 | 880 1985 BRITISH JOURNAL OF DERMATOLOGY 113:141-144 POWELL RJ; ALLEN BR; JENKINS JS; STEELE L; HUNNEYBALL I; MAURICE PDL; LITTLEWOOD SM INVESTIGATION AND TREATMENT OF OROGENITAL ULCERATION - STUDIES ON A POSSIBLE MODE OF ACTION OF THALIDOMIDE | 7 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 721 | 2 | 3 | 973 1988 LANCET 2(8610):568-568 RINGDEN O; ASCHAN J; WESTERBERG L THALIDOMIDE FOR SEVERE ACUTE GRAFT-VERSUS-HOST DISEASE | 8 | 9 |
| 722 | 11 | 33 | 995 1989 JOURNAL OF AUTOIMMUNITY 2(2):197-202 CRAIN E; MCINTOSH KR; GORDON G; PESTRONK A; DRACHMAN DB THE EFFECT OF THALIDOMIDE ON EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS | 7 | 9 |
| 723 | 1 | 7 | 1007 1990 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 8(4):427-427 HAMZA M BEHCETS-DISEASE, PALMOPLANTAR PUSTULOSIS AND HLA-B27 TREATMENT WITH THALIDOMIDE | 8 | 9 |
| 724 | 2 | 4 | 1025 1990 MEDICAL JOURNAL OF AUSTRALIA 152(7):382-383 GEORGHIOU PR; KEMP RJ HIV-ASSOCIATED ESOPHAGEAL ULCERS TREATED WITH THALIDOMIDE | 6 | 9 |
| 725 | 5 | 7 | 1077 1992 TRANSPLANTATION PROCEEDINGS 24(6):2624-2625 OSTRAAT O; EKBERG H; SCHATZ H; RIESBECK K; ERIKSSON T THALIDOMIDE PROLONGS GRAFT-SURVIVAL IN RAT CARDIAC TRANSPLANTS | 9 | 9 |
| 726 | 4 | 5 | 1089 1993 BONE MARROW TRANSPLANTATION 11(3):251-252 LOPEZ J; ULIBARRENA C; GARCIALARANA J; ODRIOZOLA J; DEOTEYZA JP; SASTRE JL; NAVARRO JL THALIDOMIDE AS THERAPY FOR INTESTINAL CHRONIC GVHD | 6 | 9 |
| 727 | 11 | 35 | 1106 1993 MOLECULAR AND CELLULAR BIOCHEMISTRY 129(2):195-200 WEGLICKI WB; STAFFORD RE; DICKENS BF; MAK IT; CASSIDY MM; PHILLIPS TM INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA BY THALIDOMIDE IN MAGNESIUM-DEFICIENCY | 4 | 9 |
| 728 | 2 | 2 | 1131 1994 BRITISH MEDICAL JOURNAL 309(6952):477-477 SMITHELLS RW THALIDOMIDE MAY BE A MUTAGEN | 8 | 9 |
| 729 | 27 | 43 | 1158 1994 POSTGRADUATE MEDICAL JOURNAL 70(830):860-862 GARDNERMEDWIN JM; POWELL RJ THALIDOMIDE - THE WAY FORWARD | 6 | 9 |
| 730 | 9 | 18 | 1165 1995 ACTA NEUROPATHOLOGICA 89(5):415-419 SCHRODER JM; SELLHAUS B; WOHRMANN T; KOGEL B; ZWINGENBERGER K INHIBITORY EFFECTS OF THALIDOMIDE ON CELLULAR PROLIFERATION, ENDONEURIAL EDEMA AND MYELIN PHAGOCYTOSIS DURING EARLY WALLERIAN DEGENERATION | 6 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 731 | 4 | 28 | 1177 1995 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 28(10):1069-1076 AARESTRUP FM; GONCALVESDACOSTA SC; SARNO EN THE EFFECT OF THALIDOMIDE ON BCG-INDUCED GRANULOMAS IN MICE | 2 | 9 |
| 732 | 6 | 40 | 1198 1995 HAUTARZT 46(8):553-560 DALLAFIOR S; PUGIN P; CERNY T; BETTICHER D; SAURAT JH; HAUSER C A CASE OF CUTANEOUS LANGERHANS CELL GRANULOMATOSIS SUCCESSFULLY TREATED WITH 2-CHLORODEOXYADENOSINE AND THALIDOMIDE | 4 | 9 |
| 733 | 11 | 14 | 1270 1996 INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY 111(1):13-17 SantosMendoza T; FavilaCastillo L; Oltra A; Tamariz J; Labarrios F; EstradaParra S; EstradaGarcia I Thalidomide and its metabolites have no effect on human lymphocyte proliferation | 7 | 9 |
| 734 | 2 | 5 | 1283 1996 LANCET 347(9006):974-974 Verberkmoes A; Boer K; Wertheim PME; Bronkhorst CM; Lange JMA Thalidomide for genital ulcer in HIV-positive woman | 4 | 9 |
| 735 | 14 | 21 | 1322 1997 CHEMTECH 27(1):21-25 Muller GW Thalidomide: From tragedy to new drug discovery | 4 | 9 |
| 736 | 4 | 29 | 1379 1997 NEUROSCIENCE LETTERS 234(2-3):123-126 Boireau A; Bordier F; Dubedat P; Peny C; Imperato A Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice | 0 | 9 |
| 737 | 8 | 14 | 1441 1998 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 66(1):61-65 Moreira AL; Kaplan G; Villahermosa LG; Fajardo TJ; Abalos RM; Cellona RV; Balagon MVF; Tan EV; Walsh GP Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL | 1 | 9 |
| 738 | 7 | 10 | 1454 1998 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 39(2):293-295 Warren KJ; Nopper AJ; Crosby DL Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus | 7 | 9 |
| 739 | 0 | 0 | 1500 1999 BLOOD 94(10):124A-124A Neben K; Hawighorst H; Moehler TM; Egerer G; Punzel M; Van Kaick G; Ho AD; Goldschmidt H Clinical response to thalidomide monotherapy correlates with improvement in dynamic magnetic resonance (d-MRI) angiogenesis parameters. | 0 | 9 |
| 740 | 0 | 0 | 1510 1999 BLOOD 94(10):316A-316A Rajkumar SV; Fonseca R; Dispenzieri A; Lacy MQ; Witzig TE; Lust JA; Kyle RA; Gertz MA; Greipp PR Thalidomide in the treatment of relapsed and refractory myeloma. | 0 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 741 | 0 | 0 | 1519 1999 BLOOD 94(10):661A-661A Raza A; Lisak L; Andrews C; Little L; Muzammil M; Alvi S; Mazzoran L; Zorat F; Akber A; Ekbal M; Razvi S; Venugopal P Thalidomide produces transfusion independence in patients with long-standing refractory anemias and myelodysplastic syndromes (MDS). | 0 | 9 |
| 742 | 3 | 44 | 1533 1999 CURRENT EYE RESEARCH 19(6):483-490 Spraul CW; Kaven C; Kampmeier J; Lang GK; Lang GE Effect of thalidomide, octreotide, and prednisolone on the migration and proliferation of RPE cells in vitro | 5 | 9 |
| 743 | 4 | 9 | 1607 2000 ACTA DERMATO-VENEREOLOGICA 80(1):24-25 Daly BM; Shuster S Antipruritic action of thalidomide | 3 | 9 |
| 744 | 16 | 59 | 1783 2000 QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS 93(5):305-311 Davey PP; Ashrafian H New therapies for heart failure: is thalidomide the answer? | 6 | 9 |
| 745 | 35 | 44 | 1804 2001 AMERICAN JOURNAL OF THE MEDICAL SCIENCES 321(5):321-326 Moraes M; Russo G Thalidomide and its dermatologic uses | 3 | 9 |
| 746 | 8 | 37 | 1897 2001 CANCER CHEMOTHERAPY AND PHARMACOLOGY 47(4):319-326 Zhou S; Paxton JW; Kestell P; Tingle MD; Ching LM In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac | 2 | 9 |
| 747 | 16 | 24 | 1950 2001 INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 55(9):627-631 Diggle GE Thalidomide: 40 years on | 7 | 9 |
| 748 | 8 | 17 | 1976 2001 LEUKEMIA & LYMPHOMA 42(4):683-+ Avigdor A; Raanani P; Levi I; Hardan I; Ben-Bassat I Extramedullary progression despite a good response in the bone marrow in patients treated with thalidomide for multiple myeloma | 8 | 9 |
| 749 | 7 | 21 | 2007 2001 SEMINARS IN ONCOLOGY 28(6):583-587 Kyle RA; Rajkumar SV Therapeutic application of thalidomide in multiple myeloma | 5 | 9 |
| 750 | 6 | 16 | 2025 2002 AMERICAN JOURNAL OF MEDICINE 112(5):412-413 Badros AZ; Siegel E; Bodenner D; Zangari M; Zeldis J; Barlogie B; Tricot G Hypothyroidism in patients with multiple myeloma following treatment with thalidomide | 8 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 751 | 3 | 14 | 2031 2002 ANNALS OF ONCOLOGY 13(7):1116-1119 Alexanian R; Weber D; Giralt S; Delasalle K Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy | 6 | 9 |
| 752 | 8 | 14 | 2038 2002 ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH 47(3):249-254 Huang F; Gu JR; Zhao W; Zhu J; Zhang JL; Yu DTY One-year open-label trial of thalidomide in ankylosing spondylitis | 3 | 9 |
| 753 | 39 | 71 | 2041 2002 BIOLOGICAL & PHARMACEUTICAL BULLETIN 25(5):597-604 Marks MG; Shi JD; Fry MO; Xiao ZL; Trzyna M; Pokala V; Ihnat MA; Li PK Effects of putative hydroxylated thalidomide metabolites on blood vessel density in the chorioallantoic membrane (CAM) assay and on tumor and endothelial cell proliferation | 6 | 9 |
| 754 | 12 | 19 | 2211 2002 INVESTIGATIONAL NEW DRUGS 20(4):389-393 Minor DR; Monroe D; Damico LA; Meng G; Suryadevara U; Elias L A phase II study of thalidomide in advanced metastatic renal cell carcinoma | 6 | 9 |
| 755 | 4 | 16 | 2249 2002 JOURNAL OF THE CHINESE CHEMICAL SOCIETY 49(3):383-385 Chang MY; Chang CH; Chen ST; Chang NC A synthesis of thalidomide | 0 | 9 |
| 756 | 7 | 8 | 2256 2002 LEUKEMIA & LYMPHOMA 43(2):351-354 Johnston RE; Abdalla SH Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia | 7 | 9 |
| 757 | 7 | 38 | 2268 2002 MICROBES AND INFECTION 4(11):1193-1202 Teo SK; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD Thalidomide in the treatment of leprosy | 7 | 9 |
| 758 | 8 | 20 | 2407 2003 BRITISH JOURNAL OF CANCER 88(6):822-827 Drake MJ; Robson W; Mehta P; Schofield I; Neal DE; Leung HY An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer | 3 | 9 |
| 759 | 0 | 0 | 27 1961 BRITISH MEDICAL JOURNAL 2(526):1223-& MEADE BW; ROSALKI SB NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 4 | 8 |
| 760 | 3 | 6 | 90 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 87(12):670-& IVES EJ THALIDOMIDE AND ANAL ABNORMALITIES | 1 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 761 | 0 | 0 | 125 1962 LANCET 1(7232):750-& WOODYATT PB THALIDOMIDE | 6 | 8 |
| 762 | 0 | 0 | 156 1962 LANCET 2(7269):1332-& LUERS H FAILURE OF MUTAGENIC ACTION OF THALIDOMIDE IN DROSOPHILA | 5 | 8 |
| 763 | 1 | 5 | 201 1963 CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE 41(7):1722-& MENARD M; ERICHOMO.L; LABROOY M; CHUBB FL QUELQUES METABOLITES POSSIBLES DE LA THALIDOMIDE | 3 | 8 |
| 764 | 2 | 3 | 229 1963 LANCET 1(728):552-& YANG T; LIANG H THALIDOMIDE AND CONGENITAL ABNORMALITIES | 0 | 8 |
| 765 | 0 | 0 | 236 1963 LANCET 1(728):959-& FRANKLIN AW PHYSICALLY HANDICAPPED BABIES - SOME THALIDOMIDE LESSONS | 0 | 8 |
| 766 | 1 | 3 | 246 1963 MEDICINA EXPERIMENTALIS 8(2):66-& GIURGEA C; MOEYERSOONS F ACTION OF THALIDOMIDE ON EEG OF CONSCIOUS, UNRESTRAINED RABBIT | 2 | 8 |
| 767 | 4 | 10 | 301 1964 SCIENCE 143(361):1343-& HIRSCHBERG E; BRYANT S; ULTMANN JE; OSNOS M THALIDOMIDE - EFFECTS ON ENZYMES OF GLUTAMIC ACID METABOLISM IN MICE | 6 | 8 |
| 768 | 7 | 23 | 311 1965 ANNALES PAEDIATRICI 205(5):341-& KAJII T THALIDOMIDE EXPERIENCE IN JAPAN | 8 | 8 |
| 769 | 17 | 29 | 436 1967 JOURNAL OF PHARMACY AND PHARMACOLOGY 19(9):603-& HAGUE DE; FABRO S; SMITH RL FATE OF [14C]THALIDOMIDE IN PREGNANT HAMSTER | 6 | 8 |
| 770 | 0 | 5 | 444 1968 ACTA ENTOMOLOGICA BOHEMOSLOVACA 65(3):212-& REZABOVA B; LANDA V EFFECTS OF THALIDOMIDE ON DEVELOPMENT OF HOUSE FLY MUSCA DOMESTICA L | 0 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 771 | 4 | 41 | 478 1969 ARZNEIMITTEL-FORSCHUNG 19(9):1544-& KOCH H INHIBITOR EFFECT OF THALIDOMIDE AND SEVERAL ANALEPTIC DRUGS ON GERMINATION AND EMBRYONIC GROWTH OF LEPIDIUM SATIVUM L | 0 | 8 |
| 772 | 2 | 13 | 507 1970 LANCET 1(7641):275-& PEMBREY ME; CLARKE CA NORMAL CHILD AFTER MATERNAL THALIDOMIDE INGESTION IN CRITICAL PERIOD OF PREGNANCY | 4 | 8 |
| 773 | 0 | 9 | 566 1973 DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY 15(6):719-727 MCFIE J; ROBERTSO.J PSYCHOLOGICAL TEST RESULTS OF CHILDREN WITH THALIDOMIDE DEFORMITIES | 1 | 8 |
| 774 | 16 | 26 | 599 1974 MONATSHEFTE FUR CHEMIE 105(1):74-79 PISCHEK G; KAISER E; KOCH H THALIDOMIDE ANALOGS .5. INVESTIGATIONS OF METABOLISM OF THALIDOMIDE-LIKE COMPOUND K-2004 | 3 | 8 |
| 775 | 2 | 11 | 616 1975 TERATOLOGY 11(1):65-72 KHERA KS FETAL CARDIOVASCULAR AND OTHER DEFECTS INDUCED BY THALIDOMIDE IN CATS | 0 | 8 |
| 776 | 13 | 145 | 662 1977 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 32(3-4):241-248 HANAUSKEABEL H; GUNZLER V INHIBITION OF HUMAN PROLYL HYDROXYLASE AS COMMON BIOCHEMICAL DENOMINATOR OF NON-SEDATIVE EFFECTS OF THALIDOMIDE IN MAN | 6 | 8 |
| 777 | 0 | 0 | 669 1978 INTERNATIONAL JOURNAL OF DERMATOLOGY 17(1):82-84 SHESKIN J STUDY WITH NINE THALIDOMIDE DERIVATIVES IN LEPRA REACTION | 3 | 8 |
| 778 | 2 | 3 | 716 1980 ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE 29(4):295-297 SCHMIDT M; SALZANO FM DISSIMILAR EFFECTS OF THALIDOMIDE IN DIZYGOTIC TWINS | 1 | 8 |
| 779 | 1 | 22 | 777 1982 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 32-1(6):613-620 FRIDERICHS E STUDIES ON THE CNS ACTIVITY PROFILE OF THALIDOMIDE ANALOGS | 0 | 8 |
| 780 | 1 | 4 | 857 1984 LANCET 2(8394):98-99 NIELSEN H; BENNIKE T THALIDOMIDE ENHANCES DEFECTIVE MONOCYTE FUNCTION IN LEPROMATOUS LEPROSY | 6 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 781 | 17 | 30 | 906 1985 REVUE NEUROLOGIQUE 141(11):719-728 CHAPON F; LECHEVALIER B; DASILVA DC; RIVRAIN Y; DUPUY B; DESCHAMPS P THALIDOMIDE INDUCED NEUROPATHY | 5 | 8 |
| 782 | 0 | 1 | 1066 1992 LANCET 339(8800):1057-1057 HAWKINS DF THALIDOMIDE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS | 7 | 8 |
| 783 | 33 | 38 | 1090 1993 BONE MARROW TRANSPLANTATION 12:S26-S28 EHNINGER G; EGER K; STUHLER A; SCHULER U THALIDOMIDE - THE NEED FOR A NEW CLINICAL-EVALUATION OF AN OLD DRUG | 7 | 8 |
| 784 | 0 | 8 | 1167 1995 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 122(9):609-611 Safa G; Joly P; Boullie MC; Thomine E; Lauret P Treatment of 2 cases of Melkersson-Rosenthal syndrome with thalidomide | 3 | 8 |
| 785 | 6 | 6 | 1185 1995 CLINICAL CHEMISTRY 41(8):1199-1199 HUUPPONEN R; PYYKKO K STABILITY OF THALIDOMIDE IN HUMAN PLASMA | 6 | 8 |
| 786 | 4 | 31 | 1194 1995 FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 12(3-4):165-174 GEIST C; WOHRMANN T; SCHNEIDER J; ZWINGENBERGER K EFFECTS OF THALIDOMIDE ON THE LOCAL SHWARTZMAN REACTION IN MICE AND RABBITS | 6 | 8 |
| 787 | 3 | 9 | 1323 1997 CLINICAL AND EXPERIMENTAL DERMATOLOGY 22(6):297-299 Darvay A; Basarab T; Russell-Jones R Thalidomide-induced toxic pustuloderma | 4 | 8 |
| 788 | 0 | 0 | 1495 1999 ARTHRITIS AND RHEUMATISM 42(10):2259-2260 Gompel A; Frances C; Piette JC; Blanc AS; Cordoliani F; Piette AM Ovarian failure with thalidomide treatment in complex aphthosis: comment on the concise communication by Ordi et al | 7 | 8 |
| 789 | 0 | 0 | 1509 1999 BLOOD 94(10):315A-315A Cheng D; Kini AR; Rodriguez J; Burt RK; Peterson LC; Traynor AE Microvascular density and cytotoxic T cell activation correlate with response to thalidomide therapy in myeloma patients. | 0 | 8 |
| 790 | 0 | 0 | 1513 1999 BLOOD 94(10):317A-317A Schiller G; Vescio R; Berenson J Thalidomide for the treatment of multiple myeloma relapsing after autologous peripheral blood progenitor cell transplant. | 0 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 791 | 9 | 33 | 1546 1999 GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY 237(12):952-961 Joussen AM; Germann T; Kirchhof B Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency | 4 | 8 |
| 792 | 5 | 17 | 1550 1999 IMMUNOPHARMACOLOGY 43(1):59-64 Dunzendorfer S; Herold M; Wiedermann CJ Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide | 8 | 8 |
| 793 | 4 | 24 | 1553 1999 INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 80(1):11-16 Arrieta O; Ortiz-Reyes A; Rembao D; Calvillo M; Rivera E; Sotelo J Protective effect of pentoxifylline plus thalidomide against septic shock in mice | 4 | 8 |
| 794 | 9 | 9 | 1561 1999 JOURNAL OF CHROMATOGRAPHY B 734(2):203-210 Torano JS; Verbon A; Guchelaar HJ Quantitative determination of thalidomide in human serum with high-performance liquid chromatography using protein precipitation with trichloroacetic acid and ultraviolet detection | 8 | 8 |
| 795 | 4 | 5 | 1573 1999 LANCET 353(9149):324-324 Klausner JD; Kaplan G; Haslett PAJ Thalidomide in toxic epidermal necrolysis | 7 | 8 |
| 796 | 14 | 17 | 1599 1999 REVUE DE MEDECINE INTERNE 20(7):567-570 de Wazieres B; Gil H; Magy N; Berthier S; Vuitton DA; Dupond JL Treatment of recurrent oro-genital ulceration with low dose of thalidomide. Pilot study in 17 patients | 3 | 8 |
| 797 | 91 | 116 | 1617 2000 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 127(6-7):603-613 Laffitte E; Revuz J Thalidomide | 7 | 8 |
| 798 | 13 | 20 | 1724 2000 IMMUNOPHARMACOLOGY 46(2):175-179 Shannon E; Aseffa A; Pankey G; Sandoval F; Lutz B Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+cells in their blood | 8 | 8 |
| 799 | 9 | 27 | 1784 2000 SEMINARS IN HEMATOLOGY 37(1):1-4 Anderson KC Thalidomide: Therapeutic potential in hematologic malignancies | 6 | 8 |
| 800 | 10 | 37 | 1791 2000 TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS 20(1):35-47 Fort DJ; Stover EL; Bantle JA; Finch RA Evaluation of the developmental toxicity of thalidomide using Frog Embryo Teratogenesis Assay-Xenopus (FETAX): Biotransformation and detoxification | 6 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 801 | 19 | 37 | 1797 2000 TOXICOLOGY AND APPLIED PHARMACOLOGY 165(3):237-244 Karrow NA; McCay JA; Brown RD; Musgrove DL; Pettit DA; Munson AE; Germolec DR; White KL Thalidomide stimulates splenic IgM antibody response and cytotoxic T lymphocyte activity and alters leukocyte subpopulation numbers in female B6C3F1 mice | 5 | 8 |
| 802 | 14 | 32 | 1826 2001 BIOORGANIC & MEDICINAL CHEMISTRY 9(4):1059-1065 Gutschow M; Hecker T; Thiele A; Hauschildt S; Eger K Aza analogues of thalidomide: Synthesis and evaluation as inhibitors of tumor necrosis factor-alpha production in vitro | 3 | 8 |
| 803 | 100 | 115 | 1913 2001 DERMATOLOGIC CLINICS 19(1):87-+ Radomsky CL; Levine N Thalidomide | 4 | 8 |
| 804 | 47 | 67 | 1920 2001 DRUGS 61(6):777-787 Bousvaros A; Mueller B Thalidomide in gastrointestinal disorders | 4 | 8 |
| 805 | 13 | 23 | 1949 2001 INTERNATIONAL IMMUNOPHARMACOLOGY 1(1):49-61 Rowland TL; McHugh SM; Deighton J; Ewan PW; Dearman RJ; Kimber I Differential effect of thalidomide and dexamethasone on the transcription factor NF-kappa B | 5 | 8 |
| 806 | 1 | 3 | 2029 2002 ANNALS OF INTERNAL MEDICINE 136(9):711-711 Escudier B; Lassau N; Leborgne S; Angevin E; Laplanche A Thalidomide and venous thrombosis | 5 | 8 |
| 807 | 15 | 47 | 2338 2003 BLOOD 101(7):2534-2541 Mesa RA; Steensma DP; Pardanani A; Li CY; Elliott M; Kaufmann SH; Wiseman G; Gray LA; Schroeder GE; Reeder T; Zeldis JB; Tefferi A A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia | 5 | 8 |
| 808 | 19 | 40 | 2418 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(4):607-616 Kropff MH; Lang N; Bisping G; Domine N; Innig G; Hentrich M; Mitterer M; Sudhoff T; Fenk R; Straka C; Heinecke A; Koch OM; Ostermann H; Berdel WE; Kienast J Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma | 4 | 8 |
| 809 | 16 | 25 | 2438 2003 CLINICAL LYMPHOMA 3(4):241-246 Seldin DC; Choufani EB; Dember LM; Wiesman JF; Berk JL; Falk RH; O'Hara C; Fennessey S; Finn KT; Wright DG; Skinner M; Sanchorawala V Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis | 4 | 8 |
| 810 | 7 | 25 | 2480 2003 JOURNAL OF CLINICAL ONCOLOGY 21(14):2732-2739 Lee CK; Barlogie B; Munshi N; Zangari M; Fassas A; Jacobson J; van Rhee F; Cottler-Fox M; Muwalla F; Tricot G DTPACE: An effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma | 2 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 811 | 7 | 26 | 2481 2003 JOURNAL OF CLINICAL ONCOLOGY 21(17):3351-3356 Hwu WJ; Krown SE; Menell JH; Panageas KS; Merrell J; Lamb LA; Williams LJ; Quinn CJ; Foster T; Chapman PB; Livingston PO; Wolchok JD; Houghton AN Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma | 1 | 8 |
| 812 | 0 | 1 | 17 1961 BRITISH MEDICAL JOURNAL 2(NOV11):1287-& SIMPSON JA NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 4 | 7 |
| 813 | 0 | 0 | 37 1961 BRITISH MEDICAL JOURNAL 2(526):1570-& HOWE P NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 6 | 7 |
| 814 | 2 | 14 | 42 1961 DISEASES OF THE NERVOUS SYSTEM 22(1):52-& NEUHAUS G; IBE K SURVIVAL FOLLOWING OVERDOSE OF THALIDOMIDE | 5 | 7 |
| 815 | 8 | 14 | 92 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 87(24):1259-& LING GM; DOLMAN CL; BOYD JR DRUG-INDUCED (THALIDOMIDE) MALFORMATIONS | 6 | 7 |
| 816 | 2 | 4 | 216 1963 EXPERIENTIA 19(12):645-& OBBINK HJK; DALDERUP LM EFFECTS OF THALIDOMIDE IN RAT FOETUS | 0 | 7 |
| 817 | 3 | 14 | 233 1963 LANCET 1(728):724-& ROSENDAL T THALIDOMIDE AND APLASIA-HYPOPLASIA OF OTIC LABYRINTH | 0 | 7 |
| 818 | 0 | 5 | 234 1963 LANCET 1(728):725-& VILLA L; ERIDANI S CYTOLOGICAL EFFECTS OF THALIDOMIDE | 4 | 7 |
| 819 | 11 | 15 | 257 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 113(3):619-& SHORB MS; POLLARD W; VASAITIS V; LUND PG; SMITH C EFFECT OF THALIDOMIDE TREATMENT OF HENS ON EMBRYONIC DEVELOPMENT AND FERTILITY | 3 | 7 |
| 820 | 2 | 4 | 260 1963 SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT 93(44):1559-& FELISATI D; NODARI R EFFETS TOXIQUES ET TERATOGENIQUES DE LA THALIDOMIDE SUR LES FOETUS DE LAPIN | 5 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 821 | 4 | 7 | 326 1965 CHEMICAL & PHARMACEUTICAL BULLETIN 13(10):1263-& TANAKA A; HASEGAWA A; URAKUBO G METABOLIC FATE OF THALIDOMIDE IN RATS | 6 | 7 |
| 822 | 8 | 13 | 386 1966 JOURNAL OF PHARMACY AND PHARMACOLOGY 18(1):46-& NICHOLLS PJ A NOTE ON ABSORPTION AND EXCRETION OF 14C-LABELLED THALIDOMIDE IN PREGNANT MICE | 7 | 7 |
| 823 | 2 | 9 | 405 1966 NATURWISSENSCHAFTEN 53(11):275-& NATARAJA.AT; NILSSON R STUDIES ON CYTOLOGICAL EFFECTS OF THALIDOMIDE AND ITS HYDROLYTIC PRODUCTS | 0 | 7 |
| 824 | 9 | 18 | 408 1966 SCIENCE 153(3733):310-& FOX RR; SAWIN PB; CRARY DD; WUEST HM INTRAVENOUS INJECTION OF THALIDOMIDE IN PREGNANT RABBITS | 6 | 7 |
| 825 | 3 | 4 | 409 1966 SCIENCE 154(3754):1362-& SCHUMACHER H; BLAKE D; GILLETTE J; WUEST HM; FOX RR THALIDOMIDE SOLUTIONS | 7 | 7 |
| 826 | 0 | 0 | 417 1967 ANATOMICAL RECORD 157(2):342-& WILSON JG; GAVAN JA THALIDOMIDE SYNDROME OF MALFORMATIONS PRODUCED IN RHESUS MONKEYS | 0 | 7 |
| 827 | 2 | 5 | 521 1971 EXPERIENTIA 27(4):421-& KOHLER F; OCKENFEL.H COMPENSATION OF TERATOGENIC EFFECT OF A THALIDOMIDE METABOLITE BY L-GLUTAMIC ACID | 3 | 7 |
| 828 | 8 | 32 | 622 1976 GEBURTSHILFE UND FRAUENHEILKUNDE 36(12):1066-1070 HOFFMANN W; GROSPIETSCH G; KUHN W GENITAL MALFORMATIONS IN THALIDOMIDE-DAMAGED GIRLS | 0 | 7 |
| 829 | 2 | 6 | 721 1980 CANADIAN JOURNAL OF PHARMACEUTICAL SCIENCES 15(2):21-23 JACKSON AJ; SCHUMACHER HJ IDENTIFICATION OF URINARY METABOLITES OF EM12 N-(2',6'- DIOXOPIPERIDEN-3'-YL)-PHTHALIMIDINE, A TERATOGENIC ANALOG OF THALIDOMIDE IN RATS AND RABBITS | 7 | 7 |
| 830 | 0 | 0 | 768 1981 TERATOLOGY 23(2):A65-A65 THEISEN CT; MCGREGOR EE FURTHER OBSERVATIONS ON THE DEVELOPMENT OF THALIDOMIDE INDUCED LIMB DEFORMITIES | 4 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 831 | 30 | 66 | 821 1983 HAUTARZT 34(2):66-72 HUNZIKER T; KREBS A THALIDOMIDE IN DERMATOLOGY | 7 | 7 |
| 832 | 21 | 38 | 832 1983 SEMAINE DES HOPITAUX 59(45):3101-3104 BELAUBE P; GARCIN G; MARCHAND JP; PRIVAT Y SHOULD THALIDOMIDE BE REHABILITATED | 4 | 7 |
| 833 | 11 | 29 | 836 1983 TERATOLOGY 27(3):327-332 PARKHIE M; WEBB M EMBRYOTOXICITY AND TERATOGENICITY OF THALIDOMIDE IN RATS | 3 | 7 |
| 834 | 0 | 2 | 851 1984 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 8(2):196-196 ROGE J; TESTAS P THALIDOMIDE IN BEHCETS SYNDROME | 6 | 7 |
| 835 | 4 | 17 | 872 1985 ACTA NEUROPATHOLOGICA 65(3-4):285-292 SCHRODER JM; MATTHIESEN T EXPERIMENTAL THALIDOMIDE NEUROPATHY - THE MORPHOLOGICAL CORRELATE OF REDUCED CONDUCTION-VELOCITY | 5 | 7 |
| 836 | 6 | 14 | 910 1986 ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY 94(6):233-237 NIELSEN H; VALERIUS NH THALIDOMIDE ENHANCES SUPEROXIDE ANION RELEASE FROM HUMAN POLYMORPHONUCLEAR AND MONONUCLEAR LEUKOCYTES | 4 | 7 |
| 837 | 0 | 3 | 964 1988 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 26(5):P623-P623 HAGUE D; SMITH RL ENIGMATIC PROPERTIES OF (+/-)-THALIDOMIDE - AN EXAMPLE OF A STABLE RACEMIC COMPOUND | 6 | 7 |
| 838 | 10 | 15 | 996 1989 JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS 488(2):417-425 WINCKLER K; KLINKMULLER KD; SCHMAHL HJ DETERMINATION OF THE THALIDOMIDE ANALOGS 2-(2,6-DIOXOPIPERIDINE-3-YL)PHTHALIMIDINE (EM 12), 2-(2,6-DIOXOPIPERIDINE-4-YL)PHTHALIMIDINE (EM 16) AND THEIR METABOLITES IN BIOLOGICAL SAMPLES | 7 | 7 |
| 839 | 4 | 8 | 1038 1991 BRITISH MEDICAL JOURNAL 302(6792):1603-1604 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 6 | 7 |
| 840 | 0 | 0 | 1044 1991 INTERNATIONAL JOURNAL OF STD & AIDS 2(5):369-370 FULLER GN; JACOBS JM; GUILOFF RJ THALIDOMIDE, PERIPHERAL NEUROPATHY AND AIDS | 5 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 841 | 4 | 6 | 1076 1992 TRANSPLANTATION PROCEEDINGS 24(6):2560-2561 ERIKSSON T; RIESBECK K; OSTRAAT O; EKBERG H; BJORKMAN S DRUG EXPOSURE AND FLOW-CYTOMETRY ANALYSES IN A THALIDOMIDE TREATMENT SCHEDULE THAT PROLONGS RAT CARDIAC GRAFT-SURVIVAL | 6 | 7 |
| 842 | 4 | 10 | 1119 1994 ARCHIVES OF TOXICOLOGY 68(3):203-205 KLUG S; FELIES A; STURJE H; NOGUEIRA AC; NEUBERT R; FRANKUS E EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NONHUMAN PRIMATE CALLITHRIX-JACCHUS .5. LACK OF TERATOGENIC EFFECTS OF PHTHALIMIDOPHTHALIMIDE | 4 | 7 |
| 843 | 1 | 1 | 1132 1994 BRITISH MEDICAL JOURNAL 309(6956):741-741 KIDA M THALIDOMIDE MAY NOT BE A MUTAGEN | 5 | 7 |
| 844 | 8 | 10 | 1184 1995 CLINICAL BIOCHEMISTRY 28(4):467-470 LYON AW; DURAN G; RAISYS VA DETERMINATION OF THALIDOMIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - METHODOLOGICAL STRATEGY FOR CLINICAL-TRIALS | 6 | 7 |
| 845 | 4 | 18 | 1206 1995 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 33(2):380-382 MANDERS SM; KOSTMAN JR; MENDEZ L; RUSSIN VL THALIDOMIDE-RESISTANT HIV-ASSOCIATED APHTHAE SUCCESSFULLY TREATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR | 1 | 7 |
| 846 | 18 | 38 | 1210 1995 LIFE SCIENCES 58(4):295-316 Neubert R; Hinz N; Thiel R; Neubert D Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide | 3 | 7 |
| 847 | 3 | 13 | 1233 1996 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 123(6-7):375-377 Cherouati K; Claudy A; Souteyrand P; Cambazard F; Vaillant L; Moulin G; Crickx B; Morel P; Lamorelle A; Revuz J Thalidomide treatment of chronic erythema multiforme recurrent and continuous variants. A retrospective study of 26 patients. | 6 | 7 |
| 848 | 10 | 22 | 1240 1996 ARCHIVES OF TOXICOLOGY 70(11):749-756 Schmahl HJ; Dencker L; Plum C; Chahoud I; Nau H Stereoselective distribution of the teratogenic thalidomide analogue EM12 in the early embryo of marmoset monkey, Wistar rat and NMRI mouse | 3 | 7 |
| 849 | 10 | 14 | 1292 1996 PEDIATRIC INFECTIOUS DISEASE JOURNAL 15(5):465-467 DeVincenzo JP; Burchet SK Prolonged thalidomide therapy for human immunodeficiency virus-associated recurrent severe esophageal and oral aphthous ulcers | 5 | 7 |
| 850 | 0 | 0 | 1363 1997 JOURNAL OF THE NATIONAL CANCER INSTITUTE 89(20):1480-1481 Saphir A Jekyll and Hyde: A new license for thalidomide? | 5 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 851 | 2 | 5 | 1428 1998 CLINICAL INFECTIOUS DISEASES 26(1):184-185 Gori A; Franzetti F; Marchetti G; Rossi C; Fusi ML; Ruzzante S; Clerici M Clinical and immunological improvement in a patient who received thalidomide treatment for refractory Mycobacterium avium complex infection | 5 | 7 |
| 852 | 8 | 24 | 1484 1999 AMERICAN JOURNAL OF PUBLIC HEALTH 89(1):98-101 Annas GJ; Elias S Thalidomide and the Titanic: Reconstructing the technology tragedies of the twentieth century | 5 | 7 |
| 853 | 0 | 0 | 1503 1999 BLOOD 94(10):125A-125A Sabir T; Raza S; Anderson L; Jagannath S Thalidomide is effective in the treatment of recurrent. Refractory multiple myeloma (MM). | 0 | 7 |
| 854 | 0 | 0 | 1516 1999 BLOOD 94(10):578A-578A Munshi N; Desikan R; Anaissie E; Zangari M; Badros A; Lim S; Toor A; Morris C; Eddlemon P; Ayers D; Roberson P; Barlogie B Peripheral blood stem cell collection (PBSC) after CAD plus G-CSF as part of Total Therapy II in newly diagnosed multiple myeloma (MM): Influence of thalidomide (THAL) administration. | 0 | 7 |
| 855 | 12 | 52 | 1559 1999 JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME 81B(1):9-23 McCredie J; Willert HG Longitudinal limb deficiencies and the sclerotomes - An analysis of 378 dysmelic malformations induced by thalidomide | 0 | 7 |
| 856 | 6 | 23 | 1572 1999 JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN 57(2):92-104 Shimazawa R; Takayama H; Hashimoto Y Development of novel biological response modifiers derived from thalidomide | 0 | 7 |
| 857 | 5 | 14 | 1579 1999 MEDICAL HYPOTHESES 53(1):76-77 Sastry PSRK Inhibition of TNF-alpha synthesis with thalidomide for prevention of acute exacerbations and altering the natural history of multiple sclerosis | 5 | 7 |
| 858 | 5 | 5 | 1608 2000 AIDS 14(12):1859-1861 Gori A; Rossi MC; Marchetti G; Trabattoni D; Molteni C; Cogliati M; Bandera A; Clerici M; Franzetti F Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease | 5 | 7 |
| 859 | 0 | 0 | 1639 2000 BLOOD 96(11):168A-168A Kropff MH; Innig G; Mitterer M; Straka C; Ostermann H; Koch OM; Berdel WE; Kienast J Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (Hyper-CDT) in primary refractory or relapsed multiple myeloma. | 0 | 7 |
| 860 | 0 | 0 | 1642 2000 BLOOD 96(11):168A-169A Raza SN; Veksler Y; Sabir T; Li ZJ; Anderson L; Jagannath S Durable response to thalidomide in relapsed/refractory multiple myeloma (MM). | 0 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 861 | 8 | 8 | 1746 2000 JOURNAL OF INFECTIOUS DISEASES 182(2):639-639 Gori A; Rossi MC; Trabattoni D; Marchetti G; Fusi ML; Molteni C; Clerici M; Franzetti F Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection | 6 | 7 |
| 862 | 1 | 2 | 1780 2000 PALLIATIVE MEDICINE 14(1):77-78 Calder K; Bruera E Thalidomide for night sweats in patients with advanced cancer | 6 | 7 |
| 863 | 4 | 18 | 1795 2000 TETRAHEDRON LETTERS 41(14):2275-2278 Luzzio FA; Mayorov AV; Figg WD Thalidomide metabolites. Part 1: Derivatives of (+)-2-(N-phthalimido)-gamma-hydroxyglutamic acid | 3 | 7 |
| 864 | 0 | 0 | 1845 2001 BLOOD 98(11):164A-164A Dimopoulos M; Panayiotidis P; Grigoraki V; Poziopoulos C; Xilouri I; Kiamouris C; Tassidou A; Gika D; Stefanoudaki K; Anagnostopoulos N; Anagnostou D Oral hyperfractionated cyclophosphamide and intermittent thalidomide-dexamethasone for previously treated patients with multiple myeloma. | 0 | 7 |
| 865 | 21 | 26 | 1958 2001 JOURNAL OF CLINICAL ONCOLOGY 19(16):3593-3595 Rajkumar SV; Kyle RA Thalidomide in the treatment of plasma cell malignancies | 6 | 7 |
| 866 | 13 | 18 | 1961 2001 JOURNAL OF CLINICAL PHARMACOLOGY 41(10):1091-1097 Aweeka F; Trapnell C; Chernoff M; Jayewardene A; Spritzler J; Bellibas SE; Lizak P; Jacobson J Pharmacokinetics and pharmacodynamics of thalidomide in HIV patients treated for oral aphthous ulcers: ACTG protocol 251 | 6 | 7 |
| 867 | 8 | 27 | 1971 2001 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 298(3):1221-1226 Drenth JPH; Vonk AG; Simon A; Powell R; Van der Meer JWM Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: A randomized, double-blind, placebo-controlled trial | 1 | 7 |
| 868 | 7 | 40 | 1995 2001 OPHTHALMOLOGICA 215(4):284-289 Kaven C; Spraul CW; Zavazava N; Lang GK; Lang GE Thalidomide and prednisolone inhibit growth factor-induced human retinal pigment epithelium cell proliferation in vitro | 2 | 7 |
| 869 | 1 | 3 | 2059 2002 BLOOD 100(4):1519-1520 Leleu X; Magro L; Fawaz A; Bauters F; Facon T; Yakoub-Agha I Efficacy of a low dose of thalidomide in advanced multiple myeloma | 7 | 7 |
| 870 | 9 | 19 | 2130 2002 BONE MARROW TRANSPLANTATION 29(7):577-580 Ahmad I; Islam T; Chanan-Khan A; Hahn T; Wentling D; Becker JL; McCarthy PL; Alam AR Myeloma - Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT | 6 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 871 | 12 | 49 | 2165 2002 CLINICAL IMMUNOLOGY 102(3):225-236 Oliver SJ; Kikuchi T; Krueger JG; Kaplan G Thalidomide induces granuloma differentiation in sarcoid skin lesions associated with disease improvement | 4 | 7 |
| 872 | 6 | 28 | 2238 2002 JOURNAL OF NUCLEAR MEDICINE 43(8):1084-1089 Kinuya S; Kawashima A; Yokoyama K; Koshida K; Konishi S; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N Cooperative effect of radioimmunotherapy and antiangiogenic therapy with thalidomide in human cancer xenografts | 1 | 7 |
| 873 | 7 | 20 | 2240 2002 JOURNAL OF PEDIATRICS 140(1):125-127 Lehman TJA; Striegel KH; Onel KB Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis | 4 | 7 |
| 874 | 21 | 29 | 2270 2002 NEUROLOGY 59(12):1872-1875 Chaudhry V; Cornblath DR; Corse A; Freimer M; Simmons-O'Brien E; Vogelsang G Thalidomide-induced neuropathy | 6 | 7 |
| 875 | 5 | 31 | 2287 2002 SEMINARS IN ONCOLOGY 29(6):34-38 Durie BGM Low-dose thalidomide in myeloma: Efficacy and biologic significance | 5 | 7 |
| 876 | 0 | 0 | 23 1961 BRITISH MEDICAL JOURNAL 2(525):1084-& HOWE P NEUROPATHY AFTER THALIDOMIDE (DISTAVAL) | 5 | 6 |
| 877 | 0 | 0 | 36 1961 BRITISH MEDICAL JOURNAL 2(526):1499-& HAYMAN DJ WITHDRAWAL OF THALIDOMIDE (DISTAVAL) | 3 | 6 |
| 878 | 0 | 0 | 141 1962 LANCET 2(7252):400-& TOMS DA; APPLEBEY M; HUNTER TAA; WOOLLAM DHM; ASHLEY DJB THALIDOMIDE AND CONGENITAL ABNORMALITIES | 4 | 6 |
| 879 | 0 | 1 | 151 1962 LANCET 2(7262):937-& CAMERON JM; CHRISTIE GA THALIDOMIDE AND CONGENITAL ABNORMALITIES | 2 | 6 |
| 880 | 0 | 5 | 215 1963 COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES 257(21):3138-& CHAMPYHATEM S SPECTROSCOPIE MOLECULAIRE - SUR LABSORPTION ULTRAVIOLETTE DU PHTALIMIDE ET DE LA THALIDOMIDE EN MILIEU ALCALIN | 3 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 881 | 0 | 1 | 265 1964 ANALYTICA CHIMICA ACTA 30(3):313-& HETMAN JS POLAROGRAPHIC DETERMINATION OF N-PHTHALYLGLUTAMIC ACID IMIDE ( THALIDOMIDE ) | 2 | 6 |
| 882 | 2 | 7 | 270 1964 ANATOMICAL RECORD 149(3):359-& MARINPADILLA M THALIDOMIDE INJURY TO IMPLANTED ARMADILLO BLASTOCYST | 3 | 6 |
| 883 | 2 | 10 | 283 1964 GANN 55(1):57-& SUGIURA K; WUEST HM EFFECT OF THALIDOMIDE ON TRANSPLANTABLE MOUSE RAT + HAMSTER TUMORS | 1 | 6 |
| 884 | 0 | 14 | 294 1964 NATURE 202(493):1080-& VASILESCU V; CONSTANTINESCU M; DIMOFTAC.C; CIURES A CYTOSPECTROPHOTOMETRIC INVESTIGATION OF ACTION OF THALIDOMIDE ON NUCLEUS OF LYMPHOCYTE | 0 | 6 |
| 885 | 4 | 5 | 346 1965 NATURE 205(4977):1241-& PARUPS EV; HOFFMAN I ABSENCE OF GROWTH EFFECTS OF THALIDOMIDE ON HIGHER PLANTS | 0 | 6 |
| 886 | 0 | 1 | 357 1965 TOXICOLOGY AND APPLIED PHARMACOLOGY 7(3):481-& DELAHUNT CS; KISS N; FELDMAN E; OAKES M SOME COMPARATIVE PHARMACOLOGICAL STUDIES IN MAN AND MONKEY WITH THALIDOMIDE | 3 | 6 |
| 887 | 1 | 4 | 488 1969 PSYCHONOMIC SCIENCE 15(1):55-& LINDBURG DG BEHAVIOR OF INFANT RHESUS MONKEYS WITH THALIDOMIDE-INDUCED MALFORMATIONS - A PILOT STUDY | 0 | 6 |
| 888 | 2 | 6 | 600 1974 PHARMACOLOGY 11(4):193-198 FICKENTS.K; KOHLER F TERATOGENICITY AND EMBRYOTOXICITY OF THALIDOMIDE AND 3-AZA-THALIDOMIDE IN MICE | 0 | 6 |
| 889 | 8 | 29 | 610 1975 ARCHIV DER PHARMAZIE 308(11):863-868 PISCHEK G; KOCH H THALIDOMIDE ANALOGS .6. BIOLOGIC HALF-LIFE OF THALIDOMIDE-LIKE COMPOUND K-2004 | 2 | 6 |
| 890 | 0 | 7 | 636 1977 ACTA ORTHOPAEDICA SCANDINAVICA 48(3):273-276 EDWARDS DH; NICHOLS PJR SPINAL ABNORMALITIES IN THALIDOMIDE EMBRYOPATHY | 4 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 891 | 3 | 8 | 770 1981 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 36(9-10):904-906 KOCHERBECKER U; KOCHER W; OCKENFELS H THALIDOMIDE-LIKE MALFORMATIONS CAUSED BY A TWEEN SURFACTANT IN MICE | 3 | 6 |
| 892 | 0 | 16 | 783 1982 EUROPEAN JOURNAL OF PEDIATRICS 138(1):77-80 VANREGEMORTER N; HAUMONT D; KIRKPATRICK C; VISEUR P; JEANTY P; DODION J; MILAIRE J; ROOZE M; RODESCH F HOLT ORAM SYNDROME MISTAKEN FOR THALIDOMIDE EMBRYOPATHY - EMBRYOLOGICAL CONSIDERATIONS | 1 | 6 |
| 893 | 13 | 34 | 818 1983 DEVELOPMENT GROWTH & DIFFERENTIATION 25(4):361-373 MCBRIDE WG; VARDY PH PATHOGENESIS OF THALIDOMIDE TERATOGENESIS IN THE MARMOSET (CALLITHRIX-JACCHUS) - EVIDENCE SUGGESTING A POSSIBLE TROPHIC INFLUENCE OF CHOLINERGIC NERVES IN LIMB MORPHOGENESIS | 1 | 6 |
| 894 | 7 | 12 | 823 1983 HAUTARZT 34(4):175-178 VOLCPLATZER B; WOLFF K TREATMENT OF SUBACUTE CUTANEOUS LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE | 3 | 6 |
| 895 | 11 | 42 | 854 1984 JOURNAL OF ANATOMY 139(OCT):397-410 MCCREDIE J; NORTH K; DEIONGH R THALIDOMIDE DEFORMITIES AND THEIR NERVE SUPPLY | 3 | 6 |
| 896 | 9 | 144 | 856 1984 JOURNAL OF THEORETICAL BIOLOGY 110(3):461-486 SHULL GE DIFFERENTIAL INHIBITION OF PROTEIN-SYNTHESIS - A POSSIBLE BIOCHEMICAL-MECHANISM OF THALIDOMIDE TERATOGENESIS | 4 | 6 |
| 897 | 5 | 14 | 860 1984 MUSCLE & NERVE 7(5):362-368 SCHWAB BW; AREZZO JC; PALDINO AM; FLOHE L; MATTHIESSEN T; SPENCER PS RABBIT SURAL NERVE RESPONSES TO CHRONIC TREATMENT WITH THALIDOMIDE AND SUPIDIMIDE | 4 | 6 |
| 898 | 6 | 13 | 902 1985 LEPROSY REVIEW 56(4):297-301 SHANNON EJ; TRUMAN RW; CHRISTY SA; BROWN LM; VADIEE R; HASTINGS RC EFFECT OF THALIDOMIDE ON INDUCTION OF ANTIBODY-SYNTHESIS IN MICE TO THE T-INDEPENDENT ANTIGEN, DNP-FICOLL | 5 | 6 |
| 899 | 4 | 17 | 905 1985 PSYCHOPHARMACOLOGY 85(1):47-50 KAITIN KI EFFECTS OF THALIDOMIDE AND PENTOBARBITAL ON NEURONAL-ACTIVITY IN THE PREOPTIC AREA DURING SLEEP AND WAKEFULNESS IN THE CAT | 3 | 6 |
| 900 | 5 | 10 | 924 1986 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 14(2):282-283 ARONSON IK; WEBER L; WEST D; BUYS C; REDER A; ANTEL J THALIDOMIDE AND LYMPHOCYTE FUNCTION | 6 | 6 |
Page 3: 1 2 3 4 5 6 7 8 9
Generated by: HistCite(Vlad).
Version: 2004.09.22